Aptevo Therapeutics Inc. (APVO) Form 8-K — Oct 23, 2026
$APVOForm 8-KItems 1.01, 3.03, 9.01Filed Oct 23, 2026, 4:05 PM ET0001193125-26-430419Original filing
Aptevo Therapeutics amended its rights agreement (poison pill) on October 23, 2026, entering Amendment No. 6 with rights agent Broadridge Corporate Issuer Solutions. The amendment extends the Final Expiration Date from October 29, 2026 to October 23, 2027 and reduces the Purchase Price from $70 to $14.56 per one one-thousandth of a Series A Junior Participating Preferred Share.
Key figures
- New expiration date
- 2027-10-23
- Prior purchase price
- $70.00
- Prior expiration date
- 2026-10-29
- Purchase price per unit
- $14.56
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.